Your browser doesn't support javascript.
loading
Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa.
Muhumuza, Richard; Ssemata, Andrew Sentoogo; Kakande, Ayoub; Ahmed, Nadia; Atujuna, Millicent; Nomvuyo, Mangxilana; Bekker, Linda-Gail; Dietrich, Janan Janine; Tshabalala, Gugulethu; Hornschuh, Stefanie; Maluadzi, Mamakiri; Chibanda-Stranix, Lynda; Nematadzira, Teacler; Weiss, Helen Anne; Nash, Stephen; Fox, Julie; Seeley, Janet.
Afiliación
  • Muhumuza R; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, P.O. Box 49, Entebbe, Uganda.
  • Ssemata AS; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, P.O. Box 49, Entebbe, Uganda.
  • Kakande A; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, P.O. Box 49, Entebbe, Uganda.
  • Ahmed N; Desmond Tutu HIV Foundation, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Atujuna M; Desmond Tutu HIV Foundation, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Nomvuyo M; Desmond Tutu HIV Foundation, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Bekker LG; Desmond Tutu HIV Foundation, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Dietrich JJ; Perinatal HIV Research Unit, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Tshabalala G; Health Systems Research Unit, South African Medical Research Council, Bellville, Cape Town, South Africa.
  • Hornschuh S; Perinatal HIV Research Unit, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Maluadzi M; Perinatal HIV Research Unit, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Chibanda-Stranix L; Perinatal HIV Research Unit, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Nematadzira T; Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe.
  • Weiss HA; Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe.
  • Nash S; MRC International Statistics & Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Fox J; MRC International Statistics & Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Seeley J; Department of Infectious Diseases, King's College London, London, UK.
Arch Sex Behav ; 50(4): 1729-1742, 2021 05.
Article en En | MEDLINE | ID: mdl-33954824
ABSTRACT
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. Few studies have explored adolescents and young people's perspectives toward PrEP. We conducted 24 group discussions and 60 in-depth interviews with males and females aged 13-24 years in Uganda, Zimbabwe, and South Africa between September 2018 and February 2019. We used the framework approach to generate themes and key concepts for analysis following the social ecological model. Young people expressed a willingness to use PrEP and identified potential barriers and facilitators of PrEP uptake. Barriers included factors at individual (fear of HIV, fear of side effects, and PrEP characteristics), interpersonal (parental influence, absence of a sexual partner), community (peer influence, social stigma), institutional (long waiting times at clinics, attitudes of health workers), and structural (cost of PrEP and mode of administration, accessibility concerns) levels. Facilitators included factors at individual (high HIV risk perception and preventing HIV/desire to remain HIV negative), interpersonal (peer influence, social support and care for PrEP uptake), community (adequate PrEP information and sensitization, evidence of PrEP efficacy and safety), institutional (convenient and responsive services, provision of appropriate and sufficiently resourced services), and structural (access and availability of PrEP, cost of PrEP) levels. The findings indicated that PrEP is an acceptable HIV prevention method. PrEP uptake is linked to personal and environmental factors that need to be considered for successful PrEP roll-out. Multi-level interventions needed to promote PrEP uptake should consider the social and structural drivers and focus on ways that can inspire PrEP uptake and limit the barriers.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aceptación de la Atención de Salud / Infecciones por VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Adolescent / Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aceptación de la Atención de Salud / Infecciones por VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Adolescent / Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Año: 2021 Tipo del documento: Article